semaglutide
Semaglutide Scarcity Exacerbates 65% Rural Supply Gap
A 65% supply gap has emerged in rural hospitals as the FDA’s 503B exclusion cuts semaglutide availability, forcing an emergency scramble to keep patients on therapy. The shortage hit overnight, leaving many rural pharmacies without the keystone GLP-1 drug that supports weight-loss and heart-health programs. Medical Disclaimer: This article